alphaXiv

Menu

Explore

State of the Art

Sign In

Labs

Feedback

History
PapersBenchmarks
NH TherAguix SA
Paper thumbnail
3
04 Jan 2024
physicsbiological-physics

AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors

CNRS logoCNRSNortheastern University logoNortheastern UniversityHarvard Medical SchoolMassachusetts General HospitalUniversité Paris-Saclay logoUniversité Paris-SaclayCEA logoCEAENS de LyonInstitut CurieDana-Farber Cancer InstituteINSERMPSL Research UniversityBrigham and Women’s HospitalInstitut universitaire de France (IUF)Whitehead Institute for Biomedical ResearchUniversit Paris-SudUniversit Lyon 1Universit de LyonInstitut Lumière-MatièreNH TherAguix SAInstitut des Sciences Analytiques
Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.
There are no more papers matching your filters at the moment.

Events

  1. AI for Law

    Joel Niklaus· Hugging Face
    01/09
    Register
  2. Watch recordings
Heart In Hand

Personalize Your Feed

Install Browser Extension
We're hiring
Sign in